The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: The advances continue
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
Comprehensive Heterocyclic Chemistry II
KATRITZKY, A. R., Rees, C. W., & Scriven, E. F. V. (1997) · Medical Entomology and Zoology · Cited by 8,499
Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.11.757 · Cited by 3,289
Chemistry of Heterocyclic Compounds: Fused Pyrimidines, Part II: Purines
(1971) · Chemistry of Heterocyclic Compounds: A Series Of Monographs · doi:10.1002/9780470186886 · Cited by 2,450
Quinoline, quinazoline and acridonealkaloids
Michael, J. P. (2008) · Nat. Prod. Rep. · doi:10.1039/b612168n · Cited by 1,721
Boyd, M. R., & Paull, K. D. (1995) · Drug Development Research · doi:10.1002/ddr.430340203 · Cited by 1,572
A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives
McGrath, N. A., Brichacek, M., & Njardarson, J. T. (2010) · Journal of Chemical Education · doi:10.1021/ed1003806 · Cited by 1,188
A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase
Fry, D. W., Kraker, A. J., McMichael, A., Ambroso, L. A., Nelson, J. M., Leopold, W. R., Connors, R. W., & Bridges, A. J. (1994) · Science · doi:10.1126/science.8066447 · Cited by 806
The National Cancer Institute: cancer drug discovery and development program.
Grever, M. R., Schepartz, S. A., & Chabner, B. A. (1992) · PubMed · Cited by 722
Khan, I., Ibrar, A., Abbas, N., & Saeed, A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.005 · Cited by 469
Self-citationLuo, H., Cai, Y., Peng, Z., Liu, T., & Yang, S. (2014) · Chemistry Central Journal · doi:10.1186/1752-153x-8-1 · Cited by 428
Khan, I., Ali, S., Hameed, S., Rama, N. H., Hussain, M. T., Wadood, A., Uddin, R., Ul-Haq, Z., Khan, A., Ali, S., et al. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.034 · Cited by 309
Self-citationErratum to “New Optical Methods for Liveness Detection on Fingers”
Drahansky, M., Dolezel, M., Vana, J., Brezinova, E., Yim, J., & Shim, K. (2014) · BioMed Research International · doi:10.1155/2014/252790 · Cited by 281
Zhao, Y., Yu, B., Yang, Z., Zhang, H., Hao, L., Gao, X., & Liu, Z. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201400521 · Cited by 250
Chandrika, P. M., Yakaiah, T., Rao, A. R. R., Narsaiah, B., Reddy, N. C., Sridhar, V., & Rao, J. V. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.06.010 · Cited by 232
Jatav, V., Mishra, P., Kashaw, S., & Stables, J. P. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2007.12.003 · Cited by 231
Quinazoline derivatives: synthesis and bioactivities
Wang, D., & Gao, F. (2013) · Chemistry Central Journal · doi:10.1186/1752-153x-7-95 · Cited by 198
Quinazolines: New horizons in anticonvulsant therapy
Ugale, V. G., & Bari, S. B. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.072 · Cited by 183
Protein Kinase Inhibitors as a Therapeutic Modality
Levitzki, A. (2003) · Accounts of Chemical Research · doi:10.1021/ar0201207 · Cited by 178
Decker, M. W. (2005) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.12.003 · Cited by 166
Smits, R. A., Adami, M., Istyastono, E. P., Zuiderveld, O. P., van Dam, C. M. E., de Kanter, F. J. J., Jongejan, A., Coruzzi, G., Leurs, R., & de Esch, I. J. P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901379s · Cited by 146
Kashaw, S. K., Kashaw, V., Mishra, P., Jain, N. K., & Stables, J. P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.05.008 · Cited by 146
Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
Barbosa, M. L. D. C., Lima, L. M., Tesch, R., Sant’Anna, C. M. R., Totzke, F., Kubbutat, M. H. G., Schächtele, C., Laufer, S., & Barreiro, E. J. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.058 · Cited by 144
Quinazoline derivatives as potential anticancer agents: a patent review (2007 – 2010)
Marzaro, G., Guiotto, A., & Chilin, A. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.665876 · Cited by 140
Lu, W., Ma, J., Hu, J., et al. (2013) · Green Chemistry · doi:10.1039/c3gc41467a · Cited by 131
Synthesis of condensed quinolines and quinazolines as DNA ligands
Malecki, N., Carato, P., Rigo, B., Goossens, J., Houssin, R., Bailly, C., & Hénichart, J. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.10.014 · Cited by 108
Design, synthesis and antitumor evaluation of phenyl N-mustard-quinazoline conjugates
Marvania, B., Lee, P., Chaniyara, R., Dong, H., Suman, S., Kakadiya, R., Chou, T., Lee, T., Shah, A. K., & Su, T. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.055 · Cited by 104
Zayed, M. F., & Hassan, M. H. (2013) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.03.004 · Cited by 102
Ibrar, A., Khan, I. A., & Abbas, N. (2013) · Archiv der Pharmazie · doi:10.1002/ardp.201300041 · Cited by 96
Self-citationKhan, I. A., Zaib, S., Ibrar, A., Rama, N. H., Simpson, J., & Iqbal, J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.03.046 · Cited by 93
Self-citationZhang, J., Ren, D., Ma, Y., et al. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.05.059 · Cited by 89
Alanazi, A. M., Abdel‐Aziz, A. A. ‐., Al-Suwaidan, I. A., Abdel‐Hamide, S. G., Shawer, T. Z., & El‐Azab, A. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.029 · Cited by 75
Ji, Q., Yang, D., Wang, X., Chen, C., Deng, Q., Ge, Z., Yuan, L., Yang, X., & Liao, F. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.04.042 · Cited by 73
Mizuno, T., Mihara, M., Nakai, T., Iwai, T., & Ito, T. (2007) · Synthesis · doi:10.1055/s-2007-983808 · Cited by 70
Novel Substituted Quinazolines for Potent EGFR Tyrosine Kinase Inhibitors
Cruz‐López, O., Conejo‐García, A., Nunez, M. C., Kimatrai, M., García-Rubiño, M. E., Morales, F., Gómez‐Pérez, V., & Campos, J. M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794940824 · Cited by 62
Darras, F. H., Wehle, S., Huang, G., Sotriffer, C., & Decker, M. W. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.045 · Cited by 61
El‐Subbagh, H. I., Hassan, G. S., El‐Messery, S. M., Al‐Rashood, S. T., Al-Omary, F. A. M., Abulfadl, Y. S., & Shabayek, M. I. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.01.004 · Cited by 55
Shallal, H. M., & Russu, W. A. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.057 · Cited by 51
Synthesis of a new class of pyrrolo[3,4-h]quinazolines with antimitotic activity
Spanò, V., Montalbano, A., Carbone, A., Parrino, B., Diana, P., Cirrincione, G., Castagliuolo, I., Brun, P., Issinger, O., Tisi, S., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.014 · Cited by 51
Omar, M. A., Conrad, J., & Beifuß, U. (2014) · Tetrahedron · doi:10.1016/j.tet.2014.02.066 · Cited by 39
Ji, F., Lv, M., Yi, W., & Cai, C. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00484a · Cited by 37
Chen, X., Du, Y., Sun, H., Wang, F., Kong, L., & Sun, M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.079 · Cited by 35
Bhat, S. I., Das, U. K., & Trivedi, D. R. (2014) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.2220 · Cited by 26
Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu2/mGlu3 NAMs
Wenthur, C. J., Morrison, R. D., Daniels, J. S., Conn, P. J., & Lindsley, C. W. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.051 · Cited by 24
Arya, K., Tomar, R., & Rawat, D. S. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0689-y · Cited by 21
医薬品のプロセス研究開発 : 早い, 安い, 巧いプロセスを目指して
Mohri, S. (2001) · Journal of Synthetic Organic Chemistry Japan · Cited by 21
Nakamura, H., Horikoshi, R., Usui, T., & Ban, H. S. (2010) · MedChemComm · doi:10.1039/c0md00115e · Cited by 20
Waiker, D. K., Karthikeyan, C., Poongavanam, V., Kongsted, J., Lozach, O., Meijer, L., & Trivedi, P. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.01.044 · Cited by 19
Hanif, M. A., Khan, I. A., Rama, N. H., Noreen, S., Choudhary, M. I., Jones, P. G., & Iqbal, M. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9929-1 · Cited by 18
Self-citationInvestigation into selective debenzylation and ring cleavage of quinazoline based heterocycles
Sawatzky, E., Bukowczan, J., & Decker, M. W. (2014) · Tetrahedron Letters · doi:10.1016/j.tetlet.2014.03.109 · Cited by 12
Cited by
Biologically active quinoline and quinazoline alkaloids part I
Shang, X., Morris‐Natschke, S. L., Liu, Y., Guo, X., Xu, X., Goto, M., Li, J., Yang, G., & Lee, K. (2018) · Medicinal Research Reviews · doi:10.1002/med.21466 · Cited by 437
Metal–organic frameworks for organic transformations by photocatalysis and photothermal catalysis
Jin, H.-G., Zhao, P.-C., Qian, Y., Xiao, J.-D., Chao, Z.-S., & Jiang, H.-L. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00095a · Cited by 347
Khan, I., Zaib, S., Batool, S., Abbas, N., Ashraf, Z., Iqbal, J., & Saeed, A. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.031 · Cited by 280
Self-citation
Metadata
- Authors
- Khan, I., Ibrar, A., Ahmed, W., & Saeed, A.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 90
- Pages
- 124-169
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W1978170307
- Cited by
- 428
- References
- 50
- FWCI
- 12.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.